PRESS RELEASE
News
-
-
PRESS RELEASE
EQS-Adhoc: APONTIS PHARMA and Zentiva enter into investment agreement – Zentiva will launch a voluntary public purchase offer
APONTIS PHARMA and Zentiva enter into investment agreement for voluntary public purchase offer at EUR 10.00 per share in cash. Zentiva aims to support future growth of APONTIS PHARMA -
-
PRESS RELEASE
EV Nickel Intersects 3 New Zones of Mineralization on the Carlang Trend Including Highest Nickel Grades to Date & Significantly Extends Strike Length by 7km
EV Nickel Inc. announces successful diamond drill program on CarLang Trend confirming near surface nickel mineralization and identifying 3 new zones of large-scale mineralization over 7km of strike -
-
PRESS RELEASE
EV Nickel Confirms High-Grade Nickel at Langmuir #2 Intersecting Nickel Grades from 1.07% to 5.11%
EV Nickel Inc. reports high-grade nickel intercepts including 5.11% Ni in Langmuir #2 Nickel Zone, with assay results indicating high nickel tenor. Company plans further drilling to advance Canadian nickel supply chain -
-
-
-
PRESS RELEASE
APONTIS PHARMA with profitable revenue growth for Single Pill combinations in the first half of 2024 – forecast for the full year confirmed
APONTIS PHARMA reports profitable revenue growth with Single Pill combinations in the first half of 2024. Forecast for full year 2024 confirmed. Earnings and sales improvements noted
